A comprehensive educational reference for the amino acid compounds most relevant to holistic health practice. Each entry includes mechanism of action, clinical evidence, and PNEI axis mapping.
Educational purposes only. This library is intended for licensed health professionals and practitioners. Nothing here constitutes medical advice or a recommendation to use any compound.
BPC-157 is a 15-amino acid peptide derived from a protein found in gastric juice. It promotes angiogenesis (new blood vessel formation), modulates nitric oxide synthesis, and upregulates growth hormone receptors in tendon fibroblasts. It has demonstrated potent anti-inflammatory effects through modulation of the COX-2 pathway and prostaglandin synthesis.
Extensive preclinical evidence demonstrates efficacy in tendon and ligament healing, inflammatory bowel disease, gastric ulcer healing, and systemic anti-inflammatory effects. The compound has been studied in over 100 peer-reviewed publications. Human clinical trials are ongoing as of 2026, with the FDA PCAC advisory committee voting 8–6 in favor of adding BPC-157 to the 503A Bulks List in July 2026.
BPC-157 is one of the most clinically relevant compounds for the Neuro-Immune Axis (Axis 01) and the Gut-Brain-Immune Axis (Axis 03). Its ability to modulate both systemic inflammation and intestinal barrier integrity makes it central to the PNEI NeuroCode™ framework for inflammatory and gut-related presentations.
GHK-Cu is a naturally occurring copper-binding tripeptide present in human plasma, saliva, and urine. It activates tissue remodeling through upregulation of collagen, elastin, and glycosaminoglycan synthesis. It modulates antioxidant defense enzymes (SOD, catalase) and activates stem cell migration to sites of injury. Critically, GHK-Cu has been shown to modulate over 4,000 human genes — activating genes associated with tissue repair and suppressing genes associated with inflammation and cancer progression.
The 4,000+ gene modulation finding comes from the Broad Institute / MIT-Harvard Connectivity Map (Pickart & Margolina, 2018). A 2026 Phase 2 trial demonstrated 25% faster wound healing compared to placebo. GHK-Cu plasma levels decline from approximately 200 ng/mL at age 20 to 80 ng/mL at age 60 and 50 ng/mL at age 80 — a 75% decline that correlates with the aging phenotype.
GHK-Cu sits at the intersection of the Mitochondrial-Redox Axis (Axis 04) and the Epigenetic-Methylation Axis (Axis 07). Its gene modulation capacity makes it one of the most systemically relevant compounds in the PNEI NeuroCode™ framework, with applications in longevity, post-surgical recovery, skin aging, hair loss, and oxidative stress management.
Thymosin Alpha-1 is a 28-amino acid peptide naturally produced by the thymus gland. It functions as an immune modulator — not a stimulant — by acting on toll-like receptors (TLR2, TLR9) and dendritic cells to regulate T-cell maturation and cytokine balance. It upregulates Th1 immunity when suppressed (as in chronic infection or cancer) and downregulates Th2 overactivation (as in autoimmune conditions and allergies).
Thymosin Alpha-1 (Zadaxin) is approved in 35 countries for hepatitis B, hepatitis C, and as a cancer adjunct therapy. Clinical trials have demonstrated efficacy in sepsis, long COVID, and immune deficiency states. A 2020 Italian study showed significant reduction in mortality in COVID-19 patients receiving Thymosin Alpha-1. Over 30 years of clinical data support its safety profile.
Thymosin Alpha-1 is the primary compound for immune modulation in the PNEI NeuroCode™ framework. Its bidirectional immune regulation makes it uniquely applicable across the Neuro-Immune Axis (Axis 01) and HPT Axis (Axis 05), particularly in presentations of chronic infection, autoimmune dysregulation, long COVID, and age-related thymic decline.
Epitalon is a synthetic tetrapeptide that stimulates telomerase activity — the enzyme responsible for maintaining telomere length. It also regulates melatonin synthesis through the pineal gland and modulates the epigenome through histone acetylation. These mechanisms converge on the aging process at its most fundamental level: telomere attrition, circadian dysregulation, and epigenetic drift.
Epitalon has been studied extensively in Russian gerontology research over 40+ years, primarily by the St. Petersburg Institute of Bioregulation and Gerontology. Animal studies have demonstrated life extension of 20–30%. Human studies have shown improved telomere length, normalized melatonin levels, and reduced incidence of age-related pathology in elderly populations. The FDA PCAC advisory committee voted on Epitalon in July 2026 as part of the 503A Bulks List review.
Epitalon is the primary longevity compound in the PNEI NeuroCode™ framework, operating across the HPG and Hormone Detox Axis (Axis 06) and the Epigenetic-Methylation Axis (Axis 07). It is particularly relevant in longevity protocols, circadian rhythm restoration, and epigenetic age reversal strategies.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within mitochondrial DNA — making it one of the first identified mitochondria-derived peptides with systemic hormonal activity. It activates AMPK signaling, regulates glucose and lipid metabolism, and improves insulin sensitivity. It also translocates to the nucleus under stress conditions to regulate gene expression.
MOTS-c was first identified in 2015 (Lee et al., Cell Metabolism). Preclinical studies demonstrate significant improvements in insulin sensitivity, metabolic flexibility, and exercise performance. Human studies are in early stages. The FDA PCAC advisory committee voted 7–5 in favor of adding MOTS-c to the 503A Bulks List in July 2026 for obesity and osteoporosis indications.
MOTS-c represents a new class of signaling molecule in the PNEI NeuroCode™ framework — mitochondria-derived peptides that communicate cellular energy status to the rest of the body. It is central to the Mitochondrial-Redox Axis (Axis 04) and is particularly relevant in metabolic syndrome, insulin resistance, obesity, and exercise physiology protocols.
The PNEI NeuroCode™ Certification teaches you not just what these compounds do — but how to select, sequence, and apply them within a complete clinical framework.
Explore the Certification →